Norbert Schmitz

9PUBLICATIONS
48CO-AUTHORS
Transplantation immunologyHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 15, 2026
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study.

|Sep 25, 2024
Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials.

Georg Lenz, Hervé Tilly, Marita Ziepert

|Sep 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).

Olivier Tournilhac, Bettina Altmann, Birte Friedrichs

|Aug 16, 2024
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration.

Fabian Frontzek, Loïc Renaud, Ulrich Dührsen

|Mar 28, 2024
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial.

Michael Oertel, Marita Ziepert, Fabian Frontzek

|May 08, 2023
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.

Philipp Berning, Norbert Schmitz, Maud Ngoya

Pageof 2

Frequent Collaborators

3 joint publications

Eva Wagner-Drouet

3 joint publications

Peter Dreger

2 joint publications

Laurence de Leval

2 joint publications

Fabian Frontzek